BioHarvest Sciences Inc.
BHST | NASDAQ
$1.51
-$0.11 (-6.79%)
At close: Sep 22, 2026, 4:00 PM ET
$1.51
$0 (0.00%)
After-hours:
Sep 22, 2026, 7:46 PM ET
Company Profile
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and sale of science-based health and wellness nutraceutical solutions, as well as offering Contract Development and Manufacturing Operation (CDMO) services to third parties in the pharmaceutical, cosmeceutical, and nutrition industries.
Key Executives
| Name | Position |
|---|---|
| Zaki Rakib | Co-Founder, CEO, Executive Chairman & President |
| Bar Dichter | Chief Financial Officer |
| Ilana Belzer | Chief Operating Officer |
| David K. Ryan | Vice President of Investor Relations & Secretary |
| Jared Turner | Chief Sales Officer |
| Malkit Azachi | Vice President of Research & Development |
| Michal Abargel Sapir | Vice President of Regulatory Affairs |
| Yoheved Hagay | Co-Founder & CTO |
BioHarvest Sciences Inc.
| Country | Canada |
| IPO Date | Jan 7, 2021 |
| Industry | Agricultural - Commodities/Milling |
| Sector | Industrials |
| Employees | 89 |
| CEO | Zaki Rakib |
Contact Details
1140-625 Howe Street Vancouver,
BC V6C 2T6 Canada
Stock Details
| Ticker Symbol | BHST |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001723464 |
| CUSIP Number | 09076J207 |
| ISIN Number | CA09076J2074 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove BHST